HomeInsightsEPS

Remus Pharmaceuticals Ltd EPS

Remus Pharmaceuticals Ltd EPS

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

0.6 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

EPS

₹ 34.52

Last updated on: Jan 14, 2025

Key Highlights

  • The Earning per Share of Remus Pharmaceuticals Ltd is ₹ 34.52 as of 14 Jan 25 .

Historical P/B Ratio of Remus Pharmaceuticals Ltd

No data available

Company Fundamentals for Remus Pharmaceuticals Ltd

No data available

Market Price of Remus Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20252260.65
13 Jan 20252103.85
10 Jan 20252316
09 Jan 20252309.35
08 Jan 20252311.65
07 Jan 20252365.75
06 Jan 20252372.5
03 Jan 20252513.5
02 Jan 20252442.7
01 Jan 20252484.75

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Remus Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Market Cap of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Remus Pharmaceuticals Ltd News Hub

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

09 Nov 2024 16:57

News

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

07 Nov 2024 10:21

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 2024 15:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 2024 12:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 2024 10:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 2024 15:16

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Remus Pharmaceuticals Ltd

What is the EPS of Remus Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Remus Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Remus Pharmaceuticals Ltd EPS calculated?

The EPS of Remus Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Remus Pharmaceuticals Ltd report its EPS?

Remus Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Remus Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Remus Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Remus Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Remus Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions